相关实验视频
Updated: Jun 19, 2026

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
活体脏捐赠后的大动脉硬:一个系统的审查和元分析
Rosendo A Rodriguez1, Kylie McNeill2, Mohsen Agharazii3
1Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada rrodriguez1847@gmail.com.
BMJ open
|December 5, 2024
概括
活体脏捐赠增加了大动脉硬度捐赠后的一年,但长期影响是最小的. 这一发现可能会影响有关心血管健康的捐赠者同意讨论.
科学领域:
- 心血管科学 心血管科学
- 腎臟病學 (nephrology) 是一種醫學.
- 移植医学 移植医学
背景情况:
- 增加的大动脉硬度,通过带-大腿脉冲波速率 (cf-PWV) 测量,与不良心血管结果有关.
- 以前的研究表明,切除术后活体脏捐赠者的cf-PWV升高.
研究的目的:
- 评估活体脏捐献对cf-PWV,淋巴细胞过率 (GFR) 和血压 (BP) 的影响.
- 为了比较cf-PWV,GFR和BP变化,脏捐赠者与非切除的健康个体相比.
主要方法:
- 在切除术前和之后,对在活体脏捐赠者中测量cf-PWV的研究进行系统审查和元分析.
- 包括未经切除的健康个体作为对照,并分析年龄调整的cf-PWV参考值.
- 数据提取,偏差风险评估 (ROBINS-I),证据质量评估 (GRADE) 和使用随机效应模型的聚合效应估计.
主要成果:
- 与健康对照人群相比,在捐赠后的一年内cf-PWV显著更高 (0.4 m/s增加) (p=0.01).
- 脏切除术后GFR下降 (p<0.001) 并且仍然低于对照组 (p<0.001);静缩和静缩血压没有显著差异.
- 捐赠者和对照者之间cf-PWV的差异在捐赠后5年是无意义的 (p=0.54).
结论:
- 大动脉硬度在脏捐赠后的一年增加,独立于血压.
- 脏捐赠对大动脉硬性的长期影响似乎很小.
- 调查结果可能会为潜在的活着的脏捐赠者提供有关心血管影响的同意过程的信息.
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

